Comments on: 'Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation'.


adverse reactions, including anaphylaxis, in association with tablet sublingual immunotherapy and advise caution when undertaking in-seasonal initiation or switchover of immunotherapy. Initiation or switchover of immunotherapy should always take place under direct medical supervision in a facility prepared to treat anaphylaxis. Kuang-Chih Hsiao & Joanne… (More)
DOI: 10.1111/pai.12290